CBT Financials Cabot Corp

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Aug 9, 2026, 10:15 UTC Overview →

Growth & profitability

Revenue has grown 7.3% per year over the past 5 years.
Operating margin has expanded, at 16.7% in the latest year.
Free cash flow has grown 17.2% per year over the past 5 years.

Financial health

Total debt ($1.1B) exceeds cash ($258M); net debt is $848M.
Total debt has grown slower than revenue (0.3% vs 7.3% per year).
Operating income covered interest expense 8.2× in the latest year, up from 0.4× 5 years ago.
Total debt is 1.4× EBITDA.

Shareholder returns

Dividends have been paid for 15 consecutive years, consuming 29.0% of earnings and 24.6% of free cash flow.
The dividend has grown 3.7% per year over the past 5 years.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
2025	$3.7B	$331M	25.3%	16.7%	21.4%	8.7%	$391M	$1.1B	$258M
2024	$4.0B	$380M	24.0%	15.4%	26.7%	10.2%	$451M	$1.1B	$223M
2023	$3.9B	$445M	21.3%	13.4%	35.2%	12.3%	$351M	$1.3B	$238M
2022	$4.3B	$209M	20.5%	9.0%	23.3%	5.9%	-$111M	$1.4B	$206M
2021	$3.4B	$250M	23.4%	13.3%	26.4%	7.6%	$62M	$1.1B	$168M
2020	$2.6B	-$238M	19.1%	0.8%	-34.4%	-8.6%	$177M	$1.1B	$151M
2019	$3.3B	$157M	20.5%	9.2%	15.7%	5.2%	$139M	$1.1B	$169M
2018	$3.2B	-$113M	23.8%	4.4%	-9.8%	-3.5%	$69M	$996M	$175M
2017	$2.7B	$248M	24.2%	12.4%	16.5%	7.4%	$201M	$915M	$280M
2016	$2.4B	$147M	23.8%	10.2%	11.5%	4.8%	$280M	$914M	$200M
2015	$2.9B	-$334M	20.4%	-11.0%	-27.1%	-10.9%	$358M	$980M	$77M
2014	$3.6B	$199M	19.8%	9.2%	10.2%	4.9%	$144M	$1.1B	$67M
2013	$3.5B	$153M	18.3%	7.8%	7.8%	3.6%	$155M	$1.3B	$95M
2012	$3.3B	$388M	19.6%	8.8%	21.4%	8.8%	$134M	$1.4B	$120M
2011	$3.1B	$236M	18.0%	7.8%	15.9%	7.5%	-$35M	$699M	$286M

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
Jun '26	$982M	$6M	18.7%	10.0%	0.4%	0.2%	$37M	$1.3B	$250M
Mar '26	$904M	$68M	23.2%	14.3%	4.3%	1.7%	$32M	$1.3B	$252M
Dec '25	$849M	$73M	24.9%	15.2%	4.6%	1.9%	$57M	$1.1B	$230M
Sep '25	$899M	$43M	24.5%	15.2%	2.8%	1.1%	$155M	$1.1B	$258M
Jun '25	$923M	$101M	26.4%	18.1%	6.6%	2.6%	$188M	$1.2B	$239M
Mar '25	$936M	$94M	25.7%	17.3%	6.6%	2.5%	$1M	$1.3B	$213M
Dec '24	$955M	$93M	24.6%	16.2%	6.8%	2.6%	$47M	$1.2B	$183M
Sep '24	$1.0B	$137M	24.0%	15.0%	9.6%	3.7%	$112M	$1.1B	$223M
Jun '24	$1.0B	$109M	25.2%	16.9%	8.1%	3.0%	$155M	$1.1B	$197M
Mar '24	$1.0B	$84M	24.1%	15.3%	6.1%	2.3%	$133M	$1.2B	$206M
Dec '23	$958M	$50M	22.8%	14.2%	3.8%	1.4%	$51M	$1.3B	$244M
Sep '23	$965M	$234M	23.3%	14.7%	18.5%	6.5%	$60M	$1.3B	$238M
Jun '23	$968M	$82M	23.0%	15.5%	7.3%	2.4%	$163M	$1.2B	$220M
Mar '23	$1.0B	$75M	20.3%	12.5%	6.8%	2.1%	$111M	$1.4B	$205M
Dec '22	$965M	$54M	18.8%	10.9%	5.4%	1.5%	$17M	$1.4B	$190M
Sep '22	$1.1B	$94M	19.8%	12.9%	10.5%	2.7%	$15M	$1.4B	$206M
Jun '22	$1.1B	$97M	20.5%	14.6%	10.8%	2.7%	-$16M	$1.4B	$208M
Mar '22	$1.1B	$107M	21.2%	14.7%	11.7%	3.0%	-$31M	$1.3B	$215M
Dec '21	$968M	-$89M	20.5%	-8.6%	-11.2%	-2.7%	-$79M	$1.3B	$179M
Sep '21	$904M	$29M	19.7%	8.2%	3.1%	0.9%	$20M	$1.1B	$168M

Valuation over time

How the market has priced CBT against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has fallen from 18.9× (Mar '23) to 11.8× (Nov '26).
The price-to-sales ratio has risen from 0.9× (Mar '23) to 1.1× (Nov '26).
The dividend yield has risen from 2.1% (Mar '23) to 2.5% (Nov '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is CBT growing its revenue and profit?

Over the past 5 years, Cabot Corp's revenue has grown 7.3% per year. These are computed facts, not advice.

How much debt does CBT have?

As of FY2025, Cabot Corp reported $1.1B of total debt against $258M of cash; operating income covered interest expense 8.2×.

What is CBT's profit margin?

In FY2025, gross margin was 25.3%, operating margin 16.7%, and net margin 8.9%.

What is CBT's P/E ratio?

Cabot Corp's P/E (TTM) is 20.57 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the CBT stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 11.8× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.